BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 10914044)

  • 41. [Clinical analysis of 75 patients with nasopharyngeal non-Hodgkin's lymphoma].
    Li YH; Jiang WQ; Huang HQ; Xu RH; Lin TY; Xia ZJ; He YJ; Guan ZZ
    Ai Zheng; 2003 Apr; 22(4):401-3. PubMed ID: 12703998
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Staging 915 cases of nasopharyngeal carcinoma after simple radical radiotherapy--checkout of Fuzhou staging system (1992)].
    Gao JM; Zeng YX; Cui NJ; Lu TX; Zhao C; Xia YF; Ma J; Xie FY
    Ai Zheng; 2005 Oct; 24(10):1165-72. PubMed ID: 16219127
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment and prognosis of children with relapsed non-Hodgkin's lymphoma--a report from CCLSG-NHL 890 Study. Children's Cancer and Leukemia Study Group (CCLSG)].
    Tsurusawa M; Katano N; Asami K; Watanabe A; Koizumi S; Miyake M; Kikuta A; Iwai A; Yamamura Y; Kawano Y; Mugishima H; Sekine I; Matsushita T; Horikoshi Y; Kikuchi M; Anami K; Fujimoto T
    Gan To Kagaku Ryoho; 2000 Oct; 27(11):1695-702. PubMed ID: 11057320
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Non-Hodgkin's lymphomas in childhood: results of treatment in patients in stage III].
    Maluf Júnior PT; Britto JL; Cristofani L; Almeida MT; Odone Filho V
    Rev Hosp Clin Fac Med Sao Paulo; 1993; 48(6):278-82. PubMed ID: 8029600
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modified ProMACE-MOPP hybrid regimen with moderate-dose methotrexate for patients with primary CNS lymphoma.
    Yamanaka R; Morii K; Shinbo Y; Takeuchi S; Tamura T; Hondoh H; Takahashi H; Onda K; Takahashi H; Tanaka R
    Ann Hematol; 2005 Jul; 84(7):447-55. PubMed ID: 15747120
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment outcome and prognosis of 112 patients with nasal and nasopharyngeal peripheral T cell lymphomas].
    Zhang YJ; Ren ZM; Wu QL; He ZY; Huang Y; Xia YF; Lin TY; Cui NJ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):217-21. PubMed ID: 16875549
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical outcomes of 106 patients with peripheral T-cell lymphoma treated by standard CHOP regimen].
    Huang HQ; Peng YL; Lin XB; Sun XF; Lin TY; Xia ZJ; Li YH; Cai QQ; He YJ; Jiang WQ; Guan ZZ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1443-7. PubMed ID: 15566653
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment results of tonsillar lymphoma: a 10-year experience.
    Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
    Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advanced stage (III-IV) Burkitt's lymphoma and B-cell acute lymphoblastic leukaemia in children: kinetic and pharmacologic rationale for treatment and recent results (1979-1983).
    Murphy SB; Bowman WP; Hustu HO; Berard CW
    IARC Sci Publ; 1985; (60):405-18. PubMed ID: 3905592
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Waldeyer's ring lymphomas: treatment results and prognostic factors.
    Gurkaynak M; Cengiz M; Akyurek S; Ozyar E; Atahan IL; Tekuzman G
    Am J Clin Oncol; 2003 Oct; 26(5):437-40. PubMed ID: 14528067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.
    Hudson MM; Krasin M; Link MP; Donaldson SS; Billups C; Merchant TE; Kun L; Billet AL; Kaste S; Tarbell NJ; Howard S; Friedmann AM; Hurwitz CA; Young JA; Marcus KC; Rai S; Cowan T; Weinstein HJ
    J Clin Oncol; 2004 Nov; 22(22):4541-50. PubMed ID: 15542805
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
    Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
    Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Survival rates of sinonasal squamous cell carcinoma with the new AJCC staging system.
    Lee CH; Hur DG; Roh HJ; Rha KS; Jin HR; Rhee CS; Min YG
    Arch Otolaryngol Head Neck Surg; 2007 Feb; 133(2):131-4. PubMed ID: 17309980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-Hodgkin's lymphoma in children; diffuse lymphoblastic histology; diffuse non-lymphoblastic histology; LSA2-L2 experience.
    Wollner N
    An Esp Pediatr; 1988 Oct; 29 Suppl 34():122-6. PubMed ID: 3214018
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical, anatomo-pathologic aspects and therapeutic results in 63 malignant ORL non-Hodgkin's lymphomas in children].
    Bergeron C; Patte C; Caillaud JM; Bernard A; Bayle C; Luboinski B; Hartmann O; Kalifa C; Flamant F; Lemerle J
    Arch Fr Pediatr; 1989 Oct; 46(8):583-7. PubMed ID: 2604511
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Termination of the treatment of children with non-Hodgkin's lymphoma after its recurrence].
    Dłuzniewska A; Balwierz W; Kwinta J
    Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):882-4. PubMed ID: 2487943
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Non-Hodgkin's lymphomas in childhood. Evaluation of therapeutic results according to histopathologic criteria (Catalan Interhospital Group of Pediatric Oncology)].
    Cubells Riero J; Pardo García N; Turmo Martí J; Vela Ferrer E; Badía Torroella RM; González Rivero MA; Illa Sala J; Melo Valls M
    An Esp Pediatr; 1988 Sep; 29(3):203-7. PubMed ID: 3195869
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Non-Hodgkin's lymphoma of the nasal cavity and paranasal sinuses: clinicopathologic study of ten cases].
    Chubachi A; Miura AB; Nishimura S; Akihama T; Kuwayama A; Saitoh M; Watanuki T
    Rinsho Ketsueki; 1991 Jun; 32(6):675-80. PubMed ID: 1890745
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Treatment of extensive B-cell lymphoma in children: studies of the French Pediatric Oncology Society].
    Vannier JP; Patte C; Philip T; Zucker JM; Gentet JC; Lamagnière JP; Pein F; Rodary C
    Bull Cancer; 1988; 75(1):61-8. PubMed ID: 3258775
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heterogeneity of disease classified as stage III in Wilms tumor: a report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
    Spreafico F; Gandola L; D'Angelo P; Terenziani M; Collini P; Bianchi M; Provenzi M; Indolfi P; Pession A; Nantron M; Di Cataldo A; Marchianò A; Catania S; Fossati Bellani F; Piva L;
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):348-54. PubMed ID: 21075548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.